Alyeska Investment Group, L.P. I Teos Therapeutics, Inc. Transaction History
Alyeska Investment Group, L.P.
- $29.9 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding ITOS
# of Institutions
51Shares Held
14.1MCall Options Held
511KPut Options Held
151K-
Black Rock Inc. New York, NY3.73MShares$37.9 Million0.0% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL152KShares$1.54 Million0.01% of portfolio
-
Ea Series Trust Havertown, PA101KShares$1.03 Million0.05% of portfolio
-
Fny Investment Advisers, LLC65KShares$659,7500.27% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL60.4KShares$613,0700.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $361M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...